Lumirous Sdn Bhd. closes a Pre-Seed round funding with CellSource Co., Ltd..
LUMIROUS announced it has successfully closed a Pre-Seed round funding with CellSource Co. Ltd.. Based in Southeast Asia, LUMIROUS is a fertility support start-up company which supports those who are trying to conceive.
Based in Kuala Lumpur, Malaysia, LUMIROUS, believes that it is everyone’s birthright to have their own child. LUMIROUS is committed to creating a world where everyone gets to enjoy their birthright.
Founded and managed by Anna Yamauchi, LUMIROUS is running a one-stop online fertility platform that provides support and services to those who are trying to conceive.
In December 2021, LUMIROUS has successfully closed a Pre-Seed round funding with CellSource Co., Ltd. (CellSource). This funding will allow LUMIROUS to develop and improve its online fertility platform, lumirous.com. The company is expanding its operations and recruiting new talents to achieve its business goal - to provide more comprehensive services to its consumers. LUMIROUS is organizing a wide range of promotion activities to improve the usability of its online fertility platform - lumirous.com.
CEO: Anna Yamauchi (middle) and LUMIROUS team
Globally, infertility is on the rise but the social stigma of talking about infertility, especially in Malaysia and even Southeast Asia, remains unchanged. Those who are suffering from infertility often have no place to turn to due to the lack of platforms or organizations which offer fertility support. Most of them can only get the information that they need from the Internet, not knowing if the piece of information they get is right or not. It is crucial to be selective about the information they are getting from the Internet to ensure they have the best chances of getting pregnant. In order to achieve this goal, LUMIROUS is in partnership with fertility clinics and fertility coaches, providing accurate information, professional advice, and support to its consumers.
CellSource is a Japan-based company focusing on the development of regenerative medicine. CellSource is providing regenerative medicine and the service of processing adipose-derived stem cells to medical institutions across Japan. Apart from that, it also focuses on the development of regenerative medicine for the obstetrics and gynaecology field, especially in fertility treatment. After looking through the business model of LUMIROUS and what it has been doing, CellSource decides to invest in the Malaysia-based company, LUMIROUS through third-party allotment, to support its goals to further expand its business and network to the countries in Southeast Asia.
Overview of the investor:
Location of the headquarters: 2F, Shibuya Mitake Building, 1-19-5 Shibuya, Shibuya-ku, Tokyo
President and CEO: Masato Tsumamoto
Stock exchange listings: Tokyo Stock Exchange (TSE) Mothers (Stock Code: 4880)
Date of establishment: November 30, 2015
Official site: https://www.cellsource.co.jp
